#BEGIN_DRUGCARD DB02879

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
Not Available

# ChEBI_ID:
Not Available

# Chemical_Formula:
C6H12O12S2

# Chemical_IUPAC_Name:
[(2S,3S,4S,5S,6S)-2,5-dihydroxy-6-(hydroxymethyl)-4-(sulfooxy)oxan-3-yl]oxidanesulfonic acid

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
2,3-Di-O-Sulfo-Alpha-D-Glucopyranose

# HET_ID:
PDX

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C6H12O12S2/c7-1-2-3(8)4(17-19(10,11)12)5(6(9)16-2)18-20(13,14)15/h2-9H,1H2,(H,10,11,12)(H,13,14,15)/t2-,3-,4-,5-,6-/m0/s1

# InChI_Key:
InChIKey=ORUZACWROKWTRH-RUTHBDMASA-N

# Indication:
Not Available

# KEGG_Compound_ID:
Not Available

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
2879

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
340.282

# Molecular_Weight_Mono:
339.977017228

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1O75

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
-2.5

# Predicted_LogS:
-1.5

# Predicted_Water_Solubility:
1.03e+01 g/l

# Primary_Accession_No:
DB02879

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
46936517

# PubChem_Substance_ID:
46507774

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT02535

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
OC[C@@H]1O[C@H](O)[C@@H](OS(O)(=O)=O)[C@@H](OS(O)(=O)=O)[C@H]1O

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:21:34 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Cell membrane
lipid-anchor (Probable)

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
M88769

# Drug_Target_1_GenBank_ID_Protein:
155053

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
TP_0574

# Drug_Target_1_Gene_Sequence:
>1305 bp
GTGAAAGTGAAATACGCACTACTTTCTGCCGGAGCGCTGCAGTTGTTGGTTGTAGGCTGT
GGCTCGTCTCATCATGAGACGCACTATGGCTATGCGACGCTAAGCTATGCGGACTACTGG
GCCGGGGAGTTGGGGCAGAGTAGGGACGTGCTTTTGGCGGGTAATGCCGAGGCGGACCGC
GCGGGGGATCTCGACGCAGGCATGTTCGATGCAGTTTCTCGCGCAACCCACGGGCATGGC
GCGTTCCGTCAGCAATTTCAGTACGCGGTTGAGGTATTGGGCGAAAAGGTTCTCTCGAAG
CAGGAGACCGAAGACAGCAGGGGAAGAAAAAAGTGGGAGTACGAGACTGACCCAAGCGTT
ACTAAGATGGTGCGTGCCTCTGCGTCATTTCAGGATTTGGGAGAGGACGGGGAGATTAAG
TTTGAAGCAGTCGAGGGTGCAGTAGCGTTGGCGGATCGCGCGAGTTCCTTCATGGTTGAC
AGCGAGGAATACAAGATTACGAACGTAAAGGTTCACGGTATGAAGTTTGTCCCAGTTGCG
GTTCCTCATGAATTAAAAGGGATTGCAAAGGAGAAGTTTCACTTCGTGGAAGACTCCCGC
GTTACGGAGAATACCAACGGCCTTAAGACAATGCTCACTGAGGATAGTTTTTCTGCACGT
AAGGTAAGCAGCATGGAGAGCCCGCACGACCTTGTGGTAGACACGGTGGGTACCGTCTAC
CACAGCCGTTTTGGTTCGGACGCAGAGGCTTCTGTGATGCTGAAAAGGGCTGATGGCTCT
GAGCTGTCGCACCGTGAGTTCATCGACTATGTGATGAACTTCAACACGGTCCGCTACGAC
TACTACGGTGATGACGCGAGCTACACCAATCTGATGGCGAGTTATGGCACCAAGCACTCT
GCTGACTCCTGGTGGAAGACAGGAAGAGTGCCCCGCATTTCGTGTGGTATCAACTATGGG
TTCGATCGGTTTAAAGGTTCAGGGCCGGGATACTACAGGCTGACTTTGATTGCGAACGGG
TATAGGGACGTAGTTGCTGATGTGCGCTTCCTTCCCAAGTACGAGGGGAACATCGATATT
GGGTTGAAGGGGAAGGTGCTGACCATAGGGGGCGCGGACGCGGAGACTCTGATGGATGCT
GCAGTTGACGTGTTTGCCGATGGACAGCCTAAGCTTGTCAGCGATCAAGCGGTGAGCTTG
GGGCAGAATGTCCTCTCTGCGGATTTCACTCCCGGCACTGAGTACACGGTTGAGGTTAGG
TTCAAGGAATTCGGTTCTGTGCGTGCGAAGGTAGTGGCCCAGTAG

# Drug_Target_1_General_Function:
Not Available

# Drug_Target_1_General_References:
1372297	Weigel LM, Brandt ME, Norgard MV: Analysis of the N-terminal region of the 47-kilodalton integral membrane lipoprotein of Treponema pallidum. Infect Immun. 1992 Apr;60(4):1568-76.
2642466	Hsu PL, Chamberlain NR, Orth K, Moomaw CR, Zhang LQ, Slaughter CA, Radolf JD, Sell S, Norgard MV: Sequence analysis of the 47-kilodalton major integral membrane immunogen of Treponema pallidum. Infect Immun. 1989 Jan;57(1):196-203.
9665876	Fraser CM, Norris SJ, Weinstock GM, White O, Sutton GG, Dodson R, Gwinn M, Hickey EK, Clayton R, Ketchum KA, Sodergren E, Hardham JM, McLeod MP, Salzberg S, Peterson J, Khalak H, Richardson D, Howell JK, Chidambaram M, Utterback T, McDonald L, Artiach P, Bowman C, Cotton MD, Fujii C, Garland S, Hatch B, Horst K, Roberts K, Sandusky M, Weidman J, Smith HO, Venter JC: Complete genome sequence of Treponema pallidum, the syphilis spirochete. Science. 1998 Jul 17;281(5375):375-88.

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
3452

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
47666

# Drug_Target_1_Name:
47 kDa membrane antigen

# Drug_Target_1_Number_of_Residues:
434

# Drug_Target_1_PDB_ID:
1O75

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
Not Available

# Drug_Target_1_Protein_Sequence:
>47 kDa membrane antigen precursor
MKVKYALLSAGALQLLVVGCGSSHHETHYGYATLSYADYWAGELGQSRDVLLAGNAEADR
AGDLDAGMFDAVSRATHGHGAFRQQFQYAVEVLGEKVLSKQETEDSRGRKKWEYETDPSV
TKMVRASASFQDLGEDGEIKFEAVEGAVALADRASSFMVDSEEYKITNVKVHGMKFVPVA
VPHELKGIAKEKFHFVEDSRVTENTNGLKTMLTEDSFSARKVSSMESPHDLVVDTVGTGY
HSRFGSDAEASVMLKRADGSELSHREFIDYVMNFNTVRYDYYGDDASYTNLMASYGTKHS
ADSWWKTGRVPRISCGINYGFDRFKGSGPGYYRLTLIANGYRDVVADVRFLPKYEGNIDI
GLKGKVLTIGGADAETLMDAAVDVFADGQPKLVSDQAVSLGQNVLSADFTPGTEYTVEVR
FKEFGSVRAKVVAQ

# Drug_Target_1_Reaction:
Not Available

# Drug_Target_1_Signals:
1-19

# Drug_Target_1_Specific_Function:
This antigen is a pathogen-specific membrane immunogen. Most abundant of the membrane lipoproteins, only found so far in pathogenic treponemes, suggesting that it is an important structural moiety in the cell envelope of virulent treponemal subspecies

# Drug_Target_1_SwissProt_ID:
P29723

# Drug_Target_1_SwissProt_Name:
TA47_TREPA

# Drug_Target_1_Synonyms:
47 kDa membrane antigen precursor

# Drug_Target_1_Theoretical_pI:
5.34

# Drug_Target_1_Transmembrane_Regions:
None

#END_DRUGCARD DB02879
